detail content area
- Date2021-02-23 17:16
- Update2021-02-23 17:16
- CountersignatureDivision of Research Planning
Heart, 2020.106(4), 292-298, DOI: https://doi.org/10.1136heartjnl-2019-315240
Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation
Min-Soo Ahn, Byung Su Yoo; Junghan Yoon; Seung-Hwan Lee; Jang Young Kim; Sung Gyun Ahn; Young Jin Youn; Jun-Won Lee; Jung-Woo Son; Hye Sim Kim; Dae Ryong Kang; Hyun-Jai Cho; Hae-Young Lee; Eun Seok Jeon; Seok-Min Kang; Dong-Ju Choi; Myeong-Chan Cho
Objectives: This study evaluated the relationship between guideline adherence for recommended therapy on discharge and relevant 60-day and 1-year clinical outcomes in patients with acute heart failure (HF) with reduced ejection fraction and atrial fibrillation (AF).
Methods: Of 5625 acute patients with HF in the Korean Acute Heart Failure registry, 986 patients with HF and documented AF were analysed. Guideline adherence scores were calculated for the preion of ACE inhibitors, angiotensin receptor blockers, β-blockers, mineralocorticoid receptor antagonists and anticoagulants.
Results: In patients with HF with AF, there was a significant trend of reduced 60-day and 1-year mortality rates and the composite end point with guideline adherence. According to the Cox proportion hazard model, poor adherence was associated with a significantly higher risk of 60-day mortality (HR 4.75; 95% CI 1.77 to 12.74) and the composite end point (HR 2.36; 95% CI 1.33 to 4.18) compared with good adherence. Furthermore, poor adherence was associated with a significantly higher risk of 1-year mortality compared with moderate (HR 1.64; 95% CI 1.15 to 2.33) and good adherence (HR 2.34; 95% CI 1.39 to 3.97) and with a higher risk of the 1-year composite end point compared with good adherence (HR 1.58; 95% CI 1.07 to 2.33).
Conclusion: Better adherence to guidelines was associated with better 60-day and 1-year prognoses in patients with HF with AF.
- DOI: https://doi.org/10.1136heartjnl-2019-315240
- ISBN or ISSN: 1355-6037
- 본 연구는 질병관리본부 연구개발과제연구비를 지원받아 수행되었습니다.
- This research was supported by a fund by Research of Korea Centers for Disease Control and Prevention.